Drug intelligence / Profile preview

Fybex

Development stage
Phase 3
Lead developer
Bio Products Laboratory
Modality
Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

**Fybex** is an investigational, plasma-derived human fibrin sealant developed by Bio Products Laboratory for topical surgical hemostasis. It contains human fibrinogen and thrombin; when applied to the operative field, thrombin converts fibrinogen to fibrin, producing a localized fibrin clot that emulates the terminal stage of physiologic coagulation. Fybex was evaluated as an adjunct to standard intra-operative hemostatic procedures to reduce post-operative blood loss in adults undergoing total hip arthroplasty and total knee arthroplasty. ([clinicaltrialsregister.eu](https://www.clinicaltrialsregister.eu/ctr-search/trial/2005-001228-35/GB))

Brand names
Fybex
02

Targets

FXIIIa (Coagulation factor XIII A subunit)PLG (Plasminogen)F2 (Thrombin)F5 (Coagulation Factor V)F8 (Coagulation Factor VIIIa)F11 (Coagulation Factor XI)Coagulation Factor XIIIF2R (Protease-activated receptor 1)PAR2 (Protease-activated receptor 2)PAR4 (Protease-activated receptor 4)

Beyond the preview

Go deeper on Fybex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fybex.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call